Abstract
We report a de novo SMARCA2 missense mutation discovered on exome sequencing in a patient with myoclonic astatic epilepsy, leading to reassessment and identification of Nicolaides-Baraitser syndrome. This de novo SMARCA2 missense mutation c.3721C>G, p.Gln1241Glu is the only reported mutation on exon 26 outside the ATPase domain of SMARCA2 to be associated with Nicolaides-Baraitser syndrome and adds to chromatin remodeling as a pathway for epileptogenesis.
Original language | English |
---|---|
Journal | American Journal of Medical Genetics. Part A |
Early online date | 26 Sept 2016 |
DOIs | |
Publication status | E-pub ahead of print - 26 Sept 2016 |
Keywords
- Myoclonic astatic epilepsy
- Nicolaides-Baraitser syndrome
- SMARCA2